Skip to content

Clinical trials

Observational Carcinoma, Medullary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Medullary Phase: Observational Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20101
20111
20123
20131
20143
20151
20182
20201
20213
20222
20243
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Not yet recruiting5
Active, not recruiting4
Unknown status4
Enrolling by invitation3
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genzyme, a Sanofi Company3
National Cancer Institute (NCI)3
Aristotle University Of Thessaloniki2
British Columbia Cancer Agency2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS2
M.D. Anderson Cancer Center2
Novo Nordisk A/S2
Austral University, Argentina1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Medullary29
Pheochromocytoma4
Thyroid Neoplasms4
Neuroendocrine Tumors3
Paraganglioma3
Colorectal Neoplasms2
Fibrosis2
Lymphatic Metastasis2
Multiple Endocrine Neoplasia Type 2a2
Pituitary Neoplasms2

Trials

Showing 51 to 29 of 29. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.